Form 4: Hims & Hers Health Chief Legal Officer Sells Shares Under 10b5-1 Plan

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., sold 3,236 shares of Class A Common Stock at a price of $27.77 per share on March 31, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On March 31, 2025, Soleil Boughton, the Chief Legal Officer of Hims & Hers Health, Inc., sold 3,236 shares of Class A Common Stock.
• The sale was executed at a price of $27.77 per share.
• Following the transaction, Boughton directly owns 170,285 shares of Hims & Hers Health, Inc.
• The sale was conducted under a Rule 10b5-1 trading plan adopted on August 28, 2024.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reports a routine stock sale under a pre-arranged trading plan. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

Sales by company insiders are a common occurrence and are often viewed in the context of pre-arranged trading plans to avoid accusations of trading on inside information. The market typically assesses the size and frequency of such sales to gauge potential impact.

Stakeholder Impact

• The sale of shares by a company officer could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.

Key Dates

Keywords

Form 4, Hims & Hers Health, Soleil Boughton, Chief Legal Officer, Stock Sale, Rule 10b5-1, Insider Trading